Assets
Create Platinum Slide Series
Viewing slides 1-6 of 9
-
S0302-2838(09)01136-1.title
drag
remove slide
Title
Transurethral Resection of Non-Muscle-Invasive Bladder
Transitional Cell Cancers With or Without 5-Aminolevulinic Acid Under Visible and Fluorescent Light: Results of a Prospective,Randomised, ... Transurethral Resection of Non-Muscle-Invasive Bladder Transitional Cell Cancers With or Without ... Zoom - S0302-2838(09)01136-1.introduction drag remove slide Introduction • Treatment of patients with newly diagnosed NMIBC consist of complete TUR, but residual tumors are found in up to 78%. The high incidence of recurrence is mostly due to incomplete resection of ... • Treatment of patients with newly diagnosed NMIBC consist of complete TUR, but residual ... Zoom
-
16726
drag
remove slide
Recurrence-free survival at 12 months.
Zoom
read this article »
-
16728
drag
remove slide
Recurrence-free survival for low-risk patients at 12 months.
Zoom
read this article »
-
16730
drag
remove slide
Recurrence-free survival for high-risk patients at 12 months.
Zoom
read this article »
-
16732
drag
remove slide
Progression-free survival at 12 months.
Zoom
read this article »
Viewing slides 1-6 of 9
Copyright ©